Pivotal Therapeutics Inc. announced that it received Health Canada approval to expand the indication of OMAZEN's product line specifically for cardiovascular health. The Natural and Non-Prescription Health Products Directorate of Health Canada (NNHPD) issued Natural Product Number (NPN) NPN 80060196 with the claim that helps to maintain and support cardiovascular health and NPN 80060197 with the claim helps to support and maintain normal serum/blood triglycerides/triacylglycerol levels. These new products contain the same unique formulation and high purity as OMAZEN and will also be positioned for the professional market such as Wellness Clinics, Cardiac Rehabilitation Clinics, Sports Medicine Clinics and Private Executive Healthcare Clinics.